These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22824134)

  • 1. Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients.
    Wang D; Curtis A; Papp AC; Koletar SL; Para MF
    BMC Med Genomics; 2012 Jul; 5():32. PubMed ID: 22824134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation at the catalytic subunit of glutamate cysteine ligase contributes to the susceptibility to sporadic colorectal cancer: a pilot study.
    Bykanova MA; Solodilova MA; Azarova IE; Klyosova EY; Bushueva OY; Polonikova AA; Churnosov MI; Polonikov AV
    Mol Biol Rep; 2022 Jul; 49(7):6145-6154. PubMed ID: 35386070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity.
    Pirmohamed M; Alfirevic A; Vilar J; Stalford A; Wilkins EG; Sim E; Park BK
    Pharmacogenetics; 2000 Nov; 10(8):705-13. PubMed ID: 11186133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The glutamate-cysteine ligase catalytic subunit gene C-129T and modifier subunit gene G-23T polymorphisms and risk for coronary diseases].
    Zuo HP; Xu WJ; Luo M; Zhu ZZ; Zhu GS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):637-40. PubMed ID: 17961430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Polymorphisms of Glutamate Cysteine Ligase Genes GCLC C-129 T and GCLM C-588 T with Risk of Polycystic Ovary Syndrome in Chinese Women.
    Yang C; Xi M; Liu H; Bai H; Jiang C; Liu Q; Fan P
    Reprod Sci; 2022 Jun; 29(6):1790-1800. PubMed ID: 34642912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to sulfamethoxazole in patients with AIDS.
    Daftarian MP; Filion LG; Cameron W; Conway B; Roy R; Tropper F; Diaz-Mitoma F
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):199-204. PubMed ID: 7697529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Study Group.
    Walmsley SL; Khorasheh S; Singer J; Djurdjev O
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):498-505. PubMed ID: 9859964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in glutamate cysteine ligase confer protection against type 2 diabetes.
    Azarova I; Klyosova E; Lazarenko V; Konoplya A; Polonikov A
    Mol Biol Rep; 2020 Aug; 47(8):5793-5805. PubMed ID: 32715377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic beryllium disease and glutathione biosynthesis genes.
    Bekris LM; Viernes HM; Farin FM; Maier LA; Kavanagh TJ; Takaro TK
    J Occup Environ Med; 2006 Jun; 48(6):599-606. PubMed ID: 16766924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.
    Carr A; Tindall B; Penny R; Cooper DA
    Clin Exp Immunol; 1993 Oct; 94(1):21-5. PubMed ID: 8403509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus.
    Vieira SM; Monteiro MB; Marques T; Luna AM; Fortes MA; Nery M; Queiroz M; Dib SA; Vendramini MF; Azevedo MJ; Canani LH; Parisi MC; Pavin EJ; Giannella-Neto D; Corrêa-Giannella ML
    BMC Med Genet; 2011 Sep; 12():129. PubMed ID: 21962117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.
    Carr A; Penny R; Cooper DA
    AIDS; 1993 Jan; 7(1):65-71. PubMed ID: 8442919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.
    Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA
    Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of Glutamate-Cysteine Ligase Subunit Catalytic (GCLC) Gene in Pulmonary Tuberculosis Patients.
    Yuniastuti A; Susanti R; Mustikaningtyas D
    Pak J Biol Sci; 2017; 20(8):397-402. PubMed ID: 29023060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole.
    Alfirevic A; Vilar FJ; Alsbou M; Jawaid A; Thomson W; Ollier WE; Bowman CE; Delrieu O; Park BK; Pirmohamed M
    Pharmacogenomics; 2009 Apr; 10(4):531-40. PubMed ID: 19374512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
    Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
    Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction.
    Koide S; Kugiyama K; Sugiyama S; Nakamura S; Fukushima H; Honda O; Yoshimura M; Ogawa H
    J Am Coll Cardiol; 2003 Feb; 41(4):539-45. PubMed ID: 12598062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Severe Shock-like Reactions in Adolescents After Trimethoprim-Sulfamethoxazole Therapy.
    Rathe JA; Poole N; Melvin A
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):382-385. PubMed ID: 32955095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of GAG trinucleotide repeat and C-129T polymorphisms impairs expression of the glutamate-cysteine ligase catalytic subunit gene.
    Butticaz C; Gysin R; Cuénod M; Do KQ
    Free Radic Biol Med; 2011 Mar; 50(5):617-23. PubMed ID: 21156206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels.
    Bekris LM; Shephard C; Janer M; Graham J; McNeney B; Shin J; Zarghami M; Griffith W; Farin F; Kavanagh TJ; Lernmark A
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):221-8. PubMed ID: 17479437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.